000 01551 a2200433 4500
005 20250516034301.0
264 0 _c20111027
008 201110s 0 0 eng d
022 _a1557-9816
024 7 _a10.1016/j.trre.2010.12.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBolin, Paul
245 0 0 _aMycophenolic acid in kidney transplant patients with diabetes mellitus: does the formulation matter?
_h[electronic resource]
260 _bTransplantation reviews (Orlando, Fla.)
_cJul 2011
300 _a117-23 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAbsorption
650 0 4 _aAdministration, Oral
650 0 4 _aChemistry, Pharmaceutical
650 0 4 _aDiabetes Mellitus, Type 1
650 0 4 _aDiabetes Mellitus, Type 2
650 0 4 _aDiabetic Nephropathies
_xdrug therapy
650 0 4 _aGastric Emptying
650 0 4 _aGastrointestinal Diseases
_xchemically induced
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xpharmacokinetics
650 0 4 _aKidney Transplantation
650 0 4 _aMycophenolic Acid
_xadverse effects
650 0 4 _aTablets, Enteric-Coated
650 0 4 _aTreatment Outcome
700 1 _aGohh, Reginald
700 1 _aKandaswamy, Raja
700 1 _aShihab, Faud S
700 1 _aWiland, Anne
700 1 _aAkhlaghi, Fatemeh
700 1 _aMelancon, Keith
773 0 _tTransplantation reviews (Orlando, Fla.)
_gvol. 25
_gno. 3
_gp. 117-23
856 4 0 _uhttps://doi.org/10.1016/j.trre.2010.12.003
_zAvailable from publisher's website
999 _c20794600
_d20794600